Falls, Orthostasis, and a Stacked Medication List
A 78-year-old woman presents after her third fall in six weeks. All three occurred in the evening while rising from a chair; none involved loss of consciousness or injury beyond bruising. Her medications are lisinopril 20 mg daily, hydrochlorothiazide 25 mg daily, metoprolol tartrate 50 mg twice daily, tamsulosin 0.4 mg at bedtime, oxybutynin 5 mg twice daily, and zolpidem 5 mg at bedtime. Supine BP is 148/84 with HR 62; after three minutes standing it is 96/58 with HR 78, and she describes the same room-spinning sensation that precedes her falls. Labs: sodium 133 mEq/L, potassium 3.3 mEq/L, creatinine 1.2 mg/dL (baseline 0.9 six months ago). She lives alone, drives, and is adamant that nothing is wrong with her heart.
1. How do the orthostatic numbers and the laboratory values refine your interpretation beyond simply noting that her blood pressure falls on standing?
Read the worked answer
The drop qualifies, and the pattern matters:
- Systolic fall of 52 mmHg and diastolic fall of 26 mmHg at three minutes far exceed the consensus threshold (≥20 systolic or ≥10 diastolic), so this is orthostatic hypotension by measurement as well as by symptom.
- The heart rate response is the tell. A rise of only 16 bpm (62 to 78) is blunted. In pure volume depletion you would expect a brisk tachycardia; a blunted response points to beta-blockade (metoprolol), age-related baroreflex impairment, or both. This means her body cannot compensate, which is why the drop is symptomatic rather than silent.
- Reproduced symptoms convert a number into a diagnosis. She described the same pre-fall sensation during the measurement, so these are symptomatic orthostatic episodes, not an incidental finding. That is what makes the fall risk actionable today.
- The labs point at a mechanism. Sodium 133 with potassium 3.3 and a creatinine rise from 0.9 to 1.2 is the classic thiazide triad of hyponatremia, hypokalemia, and volume contraction. The hydrochlorothiazide is likely driving the volume state that unmasks the orthostasis, with alpha-blockade from bedtime tamsulosin and sedation from zolpidem converting hypotension into a fall.
- Note the timing. Evening falls in a patient taking bedtime tamsulosin and zolpidem suggests the peak effect window, not a random event.
2. You cannot change everything at once. Which medication changes do you make today, in what order, and how do you justify the sequencing?
Read the worked answer
First principle: rank by harm-to-benefit, not by how abnormal the number is. Her supine BP is still 148/84, so she needs antihypertensive therapy - the goal is to remove the drugs with the worst risk-to-benefit ratio, not to strip her regimen.
Change today (highest harm, least benefit):
- Stop hydrochlorothiazide. It is the most plausible driver of the hyponatremia, hypokalemia, hypovolemia, and creatinine rise. Removing it treats four problems simultaneously.
- Stop zolpidem. Sedative-hypnotic at bedtime in a patient with nighttime falls and no documented insomnia benefit. Sedation plus orthostasis is a multiplicative fall risk.
- Stop oxybutynin and reassess the urinary indication. Anticholinergic burden contributes to confusion and falls and is a well-recognized drug to avoid in this age group. Ask whether the original symptom still warrants treatment at all.
Defer, with a plan:
- Metoprolol contributes to the blunted heart rate response, but she has cardiac indications to clarify. Do not stop abruptly; review the indication and consider a dose reduction at the next visit.
- Tamsulosin is a plausible contributor, but if it is treating significant voiding symptoms, change timing rather than stopping.
- Lisinopril can be left in place for now, but recognize that with volume repletion and a creatinine of 1.2, you must recheck renal function before and after any change.
Why not all at once: if you alter five drugs simultaneously and she improves, you have learned nothing; if she worsens, you cannot attribute the cause. Three changes today, each tied to a specific harm, with everything else held and rechecked.
3. What is your follow-up and safety plan for the next two weeks, and what would make you escalate?
Read the worked answer
Monitoring:
- Repeat basic metabolic panel in 7 to 10 days (sodium, potassium, creatinine) after stopping the diuretic; check sooner if she has vomiting, diarrhea, or reduced intake.
- Home BP log with paired readings: seated after 5 minutes, then standing at 1 and 3 minutes, twice daily. Ask her to record symptoms alongside numbers so you can see whether the orthostasis is resolving.
- Ask about urinary symptoms at the follow-up visit to decide whether any bladder therapy is needed.
Fall prevention in parallel:
- Physical therapy referral for gait, balance, and transfer training; home safety review (night lighting, rugs, footwear); vision check.
- Counsel on rising in stages and on hydration.
- Driving: this is a judgment call. Three falls, all without loss of consciousness, do not automatically mandate cessation, but symptomatic orthostasis while driving would be catastrophic. Advise her not to drive until orthostasis resolves and set an explicit review date rather than issuing a vague warning.
Escalate if: presyncope persists after the medication changes, standing systolic falls below 90 with symptoms, sodium drops further, potassium does not correct, creatinine rises above baseline by more than 30%, or a fall causes head strike or injury.
Evaluation anchor: success is not a single normal BP - it is no falls, resolution of the pre-fall sensation, sodium and potassium corrected, and BP still reasonably controlled.